137 related articles for article (PubMed ID: 32095481)
21. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
Lee J; Rhee SJ; Lee S; Yu KS
Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects.
Jin X; Kim E; Huh KY; Hwang I; Cho JY; Yu KS; Lee S
Transl Clin Pharmacol; 2020 Mar; 28(1):43-54. PubMed ID: 32274380
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
Son M; Guk J; Kim Y; Woo Chae D; Heo YA; Soh D; Park K
Clin Ther; 2016 Aug; 38(8):1845-57. PubMed ID: 27422590
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men.
Choi HK; Ghim JL; Shon J; Choi YK; Jung JA
Drug Des Devel Ther; 2016; 10():3493-3499. PubMed ID: 27822013
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
[TBL] [Abstract][Full Text] [Related]
28. Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions
.
Thomas D; Liu Y; Stein H; Weimann B
Int J Clin Pharmacol Ther; 2019 Aug; 57(8):420-428. PubMed ID: 31232274
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
[No Abstract] [Full Text] [Related]
31. Bioequivalence for a Fixed-Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given Together.
Yun JN; Kan HS; Yeun JS; Kim JH; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hoe KL; Hong JH
Clin Pharmacol Drug Dev; 2021 Aug; 10(8):850-858. PubMed ID: 34190419
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
[TBL] [Abstract][Full Text] [Related]
33. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
[TBL] [Abstract][Full Text] [Related]
34. Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination.
Kim HC; Yoon DY; Lee S; Jang IJ; Hong JH; Kim J
Transl Clin Pharmacol; 2022 Jun; 30(2):112-119. PubMed ID: 35800670
[TBL] [Abstract][Full Text] [Related]
35. Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study.
Wang L; Di Y; Guo T; Ming JE; Kong F; Yin H; Zhang L; Xie F; Yang N; Ping C; Li Y; Hou J
Adv Ther; 2020 Jun; 37(6):2696-2709. PubMed ID: 32418143
[TBL] [Abstract][Full Text] [Related]
36. Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
Csonka D; Fishman V; Natarajan J; Stieltjes H; Armas D; Dishy V; Perez Ruixo JJ
Pharmacol Res Perspect; 2021 Oct; 9(5):e00846. PubMed ID: 34624174
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.
Yang E; Yoo H; Jang IJ; Yu KS; Lee S
Drug Des Devel Ther; 2021; 15():651-658. PubMed ID: 33628012
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.
Nam JH; Oh M; Kim HJ; Han SK; Kim EJ; Song GS; Kim EY; Shin JG; Ghim JL; Kim HS
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):66-74. PubMed ID: 25034618
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets.
Kim S; Ko JW; Kim JR
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691
[TBL] [Abstract][Full Text] [Related]
40. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]